Ken Valenzano, SVP, Pharmacology & Biology at AMICUS THERAPEUTICS INC (FOLD), sold 15,000 shares at $15.00 ($225K) on 2015-07-13, disclosed to the SEC on 2015-07-15.
Scheduled sale ($225k) by SVP, Pharmacology & Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 2,500 | $38K | 16.7% |
| 2 | $15.00 | 3,000 | $45K | 20.0% |
| 3 | $15.00 | 9,500 | $143K | 63.3% |
| Total | $15.00 avg | 15,000 | $225K | 100% |
| Filing → |
| FOLD | SELL | 2015-04-17 | $63K | — | Filing → |
| FOLD | SELL | 2015-03-25 | $91K | — | Filing → |
| FOLD | SELL | 2015-03-24 | $150K | — | Filing → |